SUMMARY Trehalase activity was determined in serum, liver, and kidney in alloxan treated Swiss mice and in homozygous (Ob/Ob, Db/Db) and heterozygous (Ob/+, Db/m+) diabetic mice.
only a slight increase of enzyme activity.
Further quantitative differences were noticed between the genetic and alloxan diabetic animals. The liver enzyme activity increased from 10-to more than 20-fold in the liver of the homozygous Ob/Ob and Db/Db strains and only 3-fold (not significant compared to controls) in the alloxan treated animals. The above results suggest a regulatory relationship between the genes coding for trehalase and the enzymes of glucose metabolism activity involved in the development of the metabolic anomalies of diabetes. The structural gene for trehalase may well have survived elimination of selective pressure during phylogenesis and remained part of a co-regulated group of glucose metabolising enzymes. This could explain its sensitivity to mutations affecting glucose metabolism and its sensitivity to insulin directed regulatory mechanisms.
Trehalase (glucoside 1,1 glucohydrolase, EC 3.2.1.28) is widespread in nature.' In mammals, it is present in kidney, liver, small intestine, urine, and bile. Its natural substrate, x, ac-trehalose, has, however, never been characterised in mammals. All the enzymes necessary for its synthesis are nevertheless present in the renal cortex,2 and some years ago Sacktor and Berger3 described the synthesis of 14C-trehalose by incubating rabbit renal cortex slices with 14C-glucose. In spite of these results, the biological role of trehalase in mammals remains unknown. Trehalase present in the brush border membrane of small intestine may be responsible for the hydrolysis of trehalose in the intestinal tract absorbed with food.4 Alternatively, trehalase may have no role to play in the organism whatsoever.
Serum trehalase activity has been shown to be fairly constant in the same subject, although large variations have been noticed from one person to another. 5 An increased serum trehalase activity has been Ob/+, and C57 BI Ks Orl-Db mice,9 both homozygous Db/Db and heterozygous Db/m +. As a control, we used C57 B1/6 mice. All the animals were exsanguinated through the orbital sinus. Organs were excised, rinsed in cold saline, weighed, and homogenised in cold saline (10 ml final volume) for kidneys, and sodium bicarbonate/ calcium chloride (1 mol, 0.5 mol v/v) 10 mI/I g for liver, with Ultraturrax homogeniser-disintegrator (30 sX2 at setting 20 000/min).
Trehalase activity was estimated in plasma as described previously on aliquots of 100pd.10 One unit of enzyme (U Tr) was defined as the quantity of trehalase that hydrolyses 1 smol substrate in one minute at 370C.
In each determination of trehalase activity, the conditions of steady state kinetics were respected and the activity was expressed as U Tr/g organ.
The computations were done on the logarithm, to the base 10 of 10 or 100 times the enzyme activity (units-units/g for organs). The data are thus normalised. The factor 10 or 100 avoided the introduction of negative logarithms. It has no effect on the variances.
Results
Trehalase activity in control and alloxan diabetic Swiss mice serum and organs expressed as log trehalase activity in units is shown in table 1. It can be seen that serum trehalase activity was significantly higher in the alloxan treated mouse serum than in the control mouse serum.
The liver trehalase activity appeared to be increased also, but the difference is not statistically significant because of the large variability of the results.
The kidney trehalase activity decreased slightly but significantly. The blood sugar was significantly increased in alloxan treated mice. Table la shows the antilogarithms of the results calculated in table 1.
Serum trehalase activity was 2-19 times higher in alloxan diabetic mice than in the controls and hepatic trehalase activity was 2 95 times higher, but there was a 12 % decrease in renal trehalase activity. Blood sugar was 3-6 times higher in the alloxan diabetic mice serum as compared to the control serum. Glycosuria was increased in diabetic mice (250 times, results not shown). Table 2 shows the serum, kidney, and liver trehalase activities for the heterozygous and homozygous diabetic mice strains derived from the original C57 B1/6 strain. In these strains the hyperglycaemic syndromes are considered to be related to single gene mutations." Serum trehalase activity was found to be increased in both heterozygous strains (Ob/+, Db/m+) compared to the original strain, although the difference on the logarithms is not significant for Ob/ + and only slightly significant for Db/m+. Both homozygous strains exhibited an important and significant TABLE 1 Serun, liver, and kidney trehalase activity of norimal and alloxan diabetic Swiss mice. Enizyme activity is expr-essed as log 10 for serum (10 x units/ml) and kidney (10 x units/g organ), and log 100for liver (100 x units/g organ).
The numbers indicate the average values (M), the standard deviationi (SD), anid the standard error of the meanl (SEM). t is calculated for 95 % confidenice limits.
Serum
Liver Kidney
Blood sugar No important variation of trehalase activity could be found in the kidneys of homozygous and heterozygous strains.
The blood sugar level was significantly increased in both heterozygous strains. Glycosuria was slightly positive for db/m+ mice but was negative for ob/+ mice. Table 2a shows the antilogarithms of the results calculated in table 2. In this case, there was an increase of serum trehalase activity of 1 9 times for ob/+, 70 times for ob/ob, 2-4 times for db/m+, and 9* 3 times for db/db.
For liver trehalase, the increase of activity was I * 3 times for ob/+, 11 times for ob/ob, 1 * 8 times for db/m+, and 24 times for db/db. The renal trehalase activity showed only slight variation: an increase of 1-7 times for ob/+, 1I12 for ob/ob, and 0 77 and 0 66 times for db/ + and db/db, respectively. in the heterozygous mutants and significantly lower than the percentage increase in the homozygotes. Similar results were obtained for the liver trehalase activities. The relative increase after alloxan is a little higher than the one observed in the heterozygotes and much lower than the increase observed in the homozygotes.
On the other hand, the relative blood sugar increase is of the same order with alloxan as in the homozygous strains. These results indicate a lower insulin sensitivity of trehalase levels than of those enzymes involved in blood sugar regulation. The comparison of trehalase activity in spontaneously diabetic mice and that in alloxan diabetic mice may be of value in the study of the mechanisms involved in the development of this metabolic disorder.
Since the work of Dunn et al,'U'5 alloxan is known to destroy the , cells of the islets of Langerhans thereby causing a lack of insulin. There is a morphological and functional involution of the pancreas and a progressive degranulation of the 3 cells.16 17 The ob/ob mice show moderate spontaneous diabetes with moderate hyperglycaemia, hyperinsulinaemia, and a high gluconeogenic enzyme activity. They are markedly obese.
The db/db mice show severe diabetes with higher hyperglycaemia than ob/ob mice, transitory hyperinsulinaemia, high gluconeogenic enzyme activity, and moderate obesity.
The heterozygous strains are apparently normal.'8
We nevertheless found significant hyperglycaemia compared with C57 B1/6 strain. However, trehalase in liver and serum may well be the result of the 'survival' of a gene, probably in close association with other genes, coding for enzymes involved in the regulation of glucose metabolism. In this case a correlation might be expected between the expression of these genes and the one coding for trehalase, both being sensitive to the same hormonal and genetic regulatory mechanisms.
The increase of the liver trehalase activity may thus be related to the previously noted increase of the liver enzymes involved in gluconeogenesis in the same homozygous strains.21 22 The lack of difference in Ob/+ mice and the slight increase in Db/m+ mice, as compared to the very large increase in the homozygous mice, suggests the possibility of a repression mediated mechanism. Such a repression mechanism could depend on the synthesis of a substance coded for by the modified genes. The presence of one set of normal genes out of two could be nearly enough to ensure the synthesis of an adequate amount of the repressor substance. In the absence of both sets of normal genes it could be synthesised, leading to the full expression of the structural genes coding for trehalase. Although this mechanism is compatible with our results, it remains entirely speculative and other explanations can also be offered. It should be remembered also that several different biosynthetic pathways appear to be disturbed in the genetic diabetic mouse strains, for instance, the regulation of the relative rates of synthesis of type I and type III collagens.23 These considerations, as well as the sex and strain differences in serum and liver trehalase activity (Baumann and Labat-Robert, unpublished work, and tables 1 and 2), suggest complex regulatory mechanisms for trehalase activity, one of which appears to be closely related to those involved in the metabolic determination of diabetes. 
